Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Oct 05, 2023 $34.07 $35.49 $33.58 $34.97 1 531 697
Oct 04, 2023 $35.47 $35.47 $33.84 $34.24 766 246
Oct 03, 2023 $34.57 $35.75 $34.40 $35.46 632 984
Oct 02, 2023 $35.68 $35.77 $34.18 $34.80 861 983
Sep 29, 2023 $35.36 $36.08 $35.27 $35.65 453 576
Sep 28, 2023 $37.00 $37.09 $34.81 $35.17 592 632
Sep 27, 2023 $37.71 $38.08 $36.59 $36.91 640 977
Sep 26, 2023 $36.84 $38.41 $36.73 $37.41 868 461
Sep 25, 2023 $36.17 $37.27 $35.57 $36.67 713 493
Sep 22, 2023 $36.74 $36.74 $35.57 $36.43 669 168
Sep 21, 2023 $35.83 $37.01 $35.25 $36.61 952 944
Sep 20, 2023 $36.36 $36.54 $35.53 $36.18 764 700
Sep 19, 2023 $36.14 $36.81 $35.95 $36.39 617 976
Sep 18, 2023 $37.55 $37.70 $36.02 $36.31 637 951
Sep 15, 2023 $39.20 $39.34 $37.50 $37.68 855 275
Sep 14, 2023 $41.01 $41.24 $39.21 $39.26 601 643
Sep 13, 2023 $41.40 $41.98 $40.46 $40.96 482 518
Sep 12, 2023 $40.64 $41.66 $40.27 $41.41 798 247
Sep 11, 2023 $41.23 $41.72 $40.04 $40.74 893 272
Sep 08, 2023 $41.75 $41.99 $40.70 $41.15 795 067
Sep 07, 2023 $38.34 $41.74 $38.34 $41.14 1 296 713
Sep 06, 2023 $38.23 $38.82 $38.01 $38.79 436 835
Sep 05, 2023 $37.78 $38.56 $37.78 $38.03 405 813
Sep 01, 2023 $37.04 $38.06 $37.04 $37.78 326 644
Aug 31, 2023 $36.56 $37.69 $36.00 $36.79 528 711
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT